These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 319936)

  • 1. Reduction in plasma norepinephrine during fenfluramine treatment.
    de la Vega CE; Slater S; Ziegler MG; Lake CR; Murphy DL
    Clin Pharmacol Ther; 1977 Feb; 21(2):216-21. PubMed ID: 319936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fenfluramine and its effects on the sympathetic nervous system in man (author's transl)].
    Lake CR; Coleman MD; Ziegler MG; Murphy DL
    Sem Hop; 1980 Mar 18-25; 56(11-12):595-600. PubMed ID: 6245467
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenfluramine potentiation of antihypertensive effects of thiazides.
    Lake CR; Ziegler MG; Coleman MD; Kopin IJ
    Clin Pharmacol Ther; 1980 Jul; 28(1):22-7. PubMed ID: 7389251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenfluramine lowers plasma norepinephrine in overweight subjects.
    Chernow B; Lake CR; Cook D; Coyle J; Hughes P; Coleman MD; Ziegler MG
    Int J Clin Pharmacol Res; 1983; 3(4):233-7. PubMed ID: 6678821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
    Castellani S; Ziegler MG; van Kammen DP; Alexander PE; Siris SG; Lake CR
    Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines and dopamine-beta-hydroxylase activity during therapeutic abortion induced by sulprostone.
    Saarikoski S; Selander K; Nukala E; Pystynen P
    Prostaglandins; 1980 Sep; 20(3):487-92. PubMed ID: 7422895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of E-643, a new alpha-adrenergic blocking agent.
    Kawasaki T; Uezono K; Abe I; Nakamuta S; Ueno M; Kawazoe N; Omae T
    Eur J Clin Pharmacol; 1981; 20(6):399-405. PubMed ID: 6116609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of obesity with fenfluramine.
    Persson I; Andersen U; Deckert T
    Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sympatho-adrenal system in orthostasis].
    Kaden F; Mäurer W; Schömig A; Spohr U
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():285-7. PubMed ID: 25532
    [No Abstract]   [Full Text] [Related]  

  • 11. Anorectic effectiveness of differing dosage forms of fenfluramine.
    Tisdale SA; Ervin DK
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218
    [No Abstract]   [Full Text] [Related]  

  • 12. Fenfluramine in corticosteroid-induced obesity.
    Cameron DC; Kennedy WP; Samuel PD; Crompton GK
    Curr Med Res Opin; 1972; 1(3):153-8. PubMed ID: 4589709
    [No Abstract]   [Full Text] [Related]  

  • 13. Anorectic effectiveness of various dosages of fenfluramine and placebo: a cooperative study.
    Dent RW; Preston LW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):132-43. PubMed ID: 809229
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevation of plasma dopamine-beta-hydroxylase activity during insulin-induced hypoglycemia in man.
    Okada F; Yamashita I; Suwa N; Kunita H; Hata S
    Experientia; 1975 Jan; 31(1):70-1. PubMed ID: 1112327
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of Ponderal in patients with refractory overweight].
    Myking O; Bassoe HH; Closs K
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2541-5. PubMed ID: 4589597
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical trial of a new fenfluramine preparation (Ponderax PA).
    Hooper AC
    Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
    Rosenblatt JE; Lake CR; van Kammen DP; Ziegler MG; Bunney WE
    Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules.
    Innes JA; Campbell IW; Millar J; Munro JF
    Postgrad Med J; 1975; 51 Suppl 1():160-2. PubMed ID: 768961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.